Vascular Endothelial Growth Factor
Studies from University of Texas yield new information about vascular endothelial growth factor
Published in Women's Health Law Weekly, August 30th, 2009
According to recent research from the United States, "Angiogenesis is a hallmark of malignant transformation, With improved understanding of angiogenic signaling in both the normal and malignant state, there have been a number of agents developed that target VEGF signaling, These targeted agents can affect downstream VEGF signal transduction via unique mechanisms at different cellular and extracellular locations."
"The aflibercept, or VEGF-Trap, molecule is the subject of this article, Its molecular structure, pharmacokinetic and pharmacodynamic profile, and preclinical and early clinical data in epithelial ovarian carcinoma is reviewed. For comparison, other...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Breast Cancer
Recent studies from University of California, Medical Department add new data to psychiatry - Breast Cancer Screening
Findings from A. Fileni et al in breast cancer screening reported - Greenberg Traurig, Llp
Greenberg Traurig Attorney Annapoorni Sankaran Included Among Boston Business Journal's '40 Under 40' - National Hispanic Caucus of State Legislators
Hispanic State Legislators Applaud the US Senate's Confirmation of Judge Sotomayor to the Supreme Court - Partners for Digital Equality
Partners for Digital Equality PDE, the Hispanic Association of Colleges and Universities HACU and the National Hispanic University NHU Announce Strategic Alliance - Sedo
Sedo Chief Operating Officer Named to the 2009 Boston Business Journal 40 Under 40 - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
